SCHEMBL6987990

SCHEMBL6987990

CC(CC#N)c1cc(Br)c2ncccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 3/20 0.35
CCR8 P51685 3/20 0.35
EGLN1 Q9GZT9 1/20 0.34
CCR5 P51681 2/20 0.34
PSMD14 O00487 1/20 0.34
COPS5 Q92905 1/20 0.34
LMNA P02545 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
PDE4A P27815 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4C Q08493 2/20 0.33
PDE4D Q08499 2/20 0.33
MAPT P10636 3/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
HTT P42858 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
HSP90AA1 P07900 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1065843 0.79 TDP1 (0.43) CCR1CCR8CCR5PSMD14COPS5
SCHEMBL27605709 0.78 CCR1 (0.35) CCR1CCR8CCR5PSMD14COPS5
SCHEMBL6605252 0.77 MEN1 (0.39) PDE4BMAPTKDM4EALDH1A1HTT
SCHEMBL5842794 0.75 MAPT (0.42) CCR1CCR8CCR5PSMD14COPS5
SCHEMBL4026969 0.73 ALOX15 (0.40) CCR1CCR8CCR5PSMD14COPS5
SCHEMBL6987992 0.73 CCR1 (0.35) CCR1CCR8EGLN1CCR5PSMD14
SCHEMBL662676 0.73 KDM4E (0.47) CCR1CCR8EGLN1CCR5PSMD14
SCHEMBL4025285 0.70 PDE4A (0.39) CCR1CCR8CCR5PSMD14COPS5
SCHEMBL26029320 0.70 CCR1 (0.42) CCR1CCR8CCR5PSMD14COPS5
Methane SCHEMBL27587790 0.69 HPGDS (0.41) CCR1CCR8EGLN1CCR5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363635-A1 SUBSTITUTED 8-ARYLQUINOLINE PHOSPHODIESTERASE-4 INHIBITORS Merck & Co., Inc. (US) 2003-11-26 EP disclosed
EP-1244628-A1 SUBSTITUTED 8-ARYLQUINOLINE PHOSPHODIESTERASE-4 INHIBITORS MERCK FROSST CANADA INC. (CA) 2002-10-02 EP disclosed
WO-2002069970-A1 SUBSTITUTED 8-ARYLQUINOLINE PHOSPHODIESTERASE-4 INHIBITORS MERCK & CO., INC. (US) 2002-09-12 WO disclosed
WO-2001046151-A1 SUBSTITUTED 8-ARYLQUINOLINE PHOSPHODIESTERASE-4 INHIBITORS MERCK FROSST CANADA & CO. (CA) 2001-06-28 WO disclosed